These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28269775)

  • 1. Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body Dementia.
    Alghamdi A; Vallortigara J; Howlett DR; Broadstock M; Hortobágyi T; Ballard C; Thomas AJ; O'Brien JT; Aarsland D; Attems J; Francis PT; Whitfield DR
    J Alzheimers Dis; 2017; 57(2):373-386. PubMed ID: 28269775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment.
    Whitfield DR; Vallortigara J; Alghamdi A; Howlett D; Hortobágyi T; Johnson M; Attems J; Newhouse S; Ballard C; Thomas AJ; O'Brien JT; Aarsland D; Francis PT
    Neurobiol Aging; 2014 Dec; 35(12):2836-2844. PubMed ID: 25104558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia.
    Vallortigara J; Rangarajan S; Whitfield D; Alghamdi A; Howlett D; Hortobágyi T; Johnson M; Attems J; Ballard C; Thomas A; O'Brien J; Aarsland D; Francis P
    F1000Res; 2014; 3():108. PubMed ID: 25671083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and pathological correlates of cognitive and behavioural change in DLB/PDD.
    Francis PT
    J Neurol; 2009 Aug; 256 Suppl 3():280-5. PubMed ID: 19711117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
    Jellinger KA; Korczyn AD
    BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia.
    Bereczki E; Francis PT; Howlett D; Pereira JB; Höglund K; Bogstedt A; Cedazo-Minguez A; Baek JH; Hortobágyi T; Attems J; Ballard C; Aarsland D
    Alzheimers Dement; 2016 Nov; 12(11):1149-1158. PubMed ID: 27224930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
    Jellinger KA
    J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration.
    Chai YL; Chong JR; Weng J; Howlett D; Halsey A; Lee JH; Attems J; Aarsland D; Francis PT; Chen CP; Lai MKP
    Brain Pathol; 2019 Jan; 29(1):63-74. PubMed ID: 30051532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
    Sierra M; Gelpi E; Martí MJ; Compta Y
    Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
    Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L
    Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies.
    Barrachina M; Castaño E; Dalfó E; Maes T; Buesa C; Ferrer I
    Neurobiol Dis; 2006 May; 22(2):265-73. PubMed ID: 16380264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias.
    Datta A; Chai YL; Tan JM; Lee JH; Francis PT; Chen CP; Sze SK; Lai MKP
    Mol Brain; 2017 Aug; 10(1):36. PubMed ID: 28800743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential insular cortex subregional vulnerability to α-synuclein pathology in Parkinson's disease and dementia with Lewy bodies.
    Fathy YY; Jonker AJ; Oudejans E; de Jong FJJ; van Dam AW; Rozemuller AJM; van de Berg WDJ
    Neuropathol Appl Neurobiol; 2019 Apr; 45(3):262-277. PubMed ID: 29797340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A soluble tau fragment generated by caspase-2 is associated with dementia in Lewy body disease.
    Smith BR; Nelson KM; Kemper LJ; Leinonen-Wright K; Petersen A; Keene CD; Ashe KH
    Acta Neuropathol Commun; 2019 Jul; 7(1):124. PubMed ID: 31362787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathological and clinical comparison of Parkinson’s disease dementia and dementia with Lewy bodies].
    Bencs V; Bencze J; Módis VL; Simon V; Kálmán J; Hortobágyi T
    Orv Hetil; 2020 May; 161(18):727-737. PubMed ID: 32338488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias.
    Howlett DR; Whitfield D; Johnson M; Attems J; O'Brien JT; Aarsland D; Lai MK; Lee JH; Chen C; Ballard C; Hortobágyi T; Francis PT
    Brain Pathol; 2015 Jul; 25(4):401-8. PubMed ID: 25103200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases.
    Ruffmann C; Calboli FC; Bravi I; Gveric D; Curry LK; de Smith A; Pavlou S; Buxton JL; Blakemore AI; Takousis P; Molloy S; Piccini P; Dexter DT; Roncaroli F; Gentleman SM; Middleton LT
    Neuropathol Appl Neurobiol; 2016 Aug; 42(5):436-50. PubMed ID: 26527105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems.
    MacInnes N; Iravani MM; Perry E; Piggott M; Perry R; Jenner P; Ballard C
    J Neural Transm (Vienna); 2008 Jun; 115(6):869-78. PubMed ID: 18401540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort.
    van Steenoven I; Aarsland D; Weintraub D; Londos E; Blanc F; van der Flier WM; Teunissen CE; Mollenhauer B; Fladby T; Kramberger MG; Bonanni L; Lemstra AW;
    J Alzheimers Dis; 2016 Aug; 54(1):287-95. PubMed ID: 27567832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies.
    Obi K; Akiyama H; Kondo H; Shimomura Y; Hasegawa M; Iwatsubo T; Mizuno Y; Mochizuki H
    Exp Neurol; 2008 Apr; 210(2):409-20. PubMed ID: 18164295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.